Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

Cogent Biosciences (COGT) Interest & Investment Income (2017 - 2021)

Cogent Biosciences has reported Interest & Investment Income over the past 5 years, most recently at $107000.0 for Q4 2021.

  • Quarterly results put Interest & Investment Income at $107000.0 for Q4 2021, up 50.7% from a year ago — trailing twelve months through Dec 2021 was $467000.0 (up 224.31% YoY), and the annual figure for FY2025 was $14.7 million, down 18.79%.
  • Interest & Investment Income for Q4 2021 was $107000.0 at Cogent Biosciences, down from $115000.0 in the prior quarter.
  • Over the last five years, Interest & Investment Income for COGT hit a ceiling of $408000.0 in Q4 2018 and a floor of $3000.0 in Q2 2020.
  • Median Interest & Investment Income over the past 5 years was $98000.0 (2017), compared with a mean of $120850.0.
  • Biggest five-year swings in Interest & Investment Income: tumbled 92.35% in 2019 and later surged 3900.0% in 2021.
  • Cogent Biosciences' Interest & Investment Income stood at $99000.0 in 2017, then skyrocketed by 312.12% to $408000.0 in 2018, then plummeted by 85.05% to $61000.0 in 2019, then grew by 16.39% to $71000.0 in 2020, then soared by 50.7% to $107000.0 in 2021.
  • The last three reported values for Interest & Investment Income were $107000.0 (Q4 2021), $115000.0 (Q3 2021), and $120000.0 (Q2 2021) per Business Quant data.